Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2013 | 10-2012 | 07-2012 | 04-2012 | 01-2012 | |
| Sales | 194 | 58 | 209 | 168 | 167 |
| Cost of Goods | 171 | 44 | 187 | 145 | 188 |
| Gross Profit | 23 | 14 | 23 | 23 | -21 |
| Operating Expenses | 23 | 39 | 94 | 35 | 19 |
| Operating Income | -1 | -25 | -71 | -12 | -39 |
| Interest Expense | 0 | 0 | 0 | 4 | 4 |
| Other Income | 16 | -4 | 8 | 16 | 43 |
| Pre-tax Income | 15 | -30 | -64 | N/A | N/A |
| Net Income Continuous | 15 | -30 | -64 | 45 | -40 |
| Net Income | $15 | $-30 | $-64 | $45 | $-40 |
| EBITDA(a) | $16 | $-29 | $-63 | $-11 | $-39 |